Greenville Health System

Easley, South Carolina 29640

0 studies enrolling now · 3 studies all time

What they study most

Advanced Breast Cancer, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Malignant Melanoma, Metastatic Breast Cancer, Myelodysplastic Syndrome

Studies at this site

• Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) — Completed
• Palbociclib in Real World Practice — Completed
• Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma — NO_LONGER_AVAILABLE